Efficacy and safety of transcranial pulse stimulation in young adolescents with attention-deficit/hyperactivity disorder: a pilot, randomized, double-blind, sham-controlled trial

Teris Cheung (Corresponding Author), Benjamin K. Yee, Bolton Chau, Joyce Yuen Ting Lam, Kwan Hin Fong, Herman Lo, Tim Man Ho Li, Albert Martin Li, Lei Sun, Roland Beisteiner, Calvin Pak Wing Cheng (Corresponding Author)

Research output: Journal article publicationJournal articleAcademic researchpeer-review

Abstract

Background: This is the first study to evaluate the efficacy and safety of transcranial pulse stimulation (TPS) for the treatment of attention-deficit/hyperactivity disorder (ADHD) among young adolescents in Hong Kong. Methods: This double-blind, randomized, sham-controlled trial included a TPS group and a sham TPS group, encompassing a total of 30 subjects aged 12–17 years who were diagnosed with ADHD. Baseline measurements SNAP-IV, ADHD RS-IV, CGI and executive functions (Stroop tests, Digit Span) and post-TPS evaluation were collected. Both groups were assessed at baseline, immediately after intervention, and at 1-month and 3-month follow-ups. Repeated-measures ANOVAs were used to analyze data. Results: The TPS group exhibited a 30% reduction in the mean SNAP-IV score at postintervention that was maintained at 1- and 3-month follow-ups. Conclusion: TPS is an effective and safe adjunct treatment for the clinical management of ADHD. Clinical trial registration: ClinicalTrials.Gov, identifier NCT05422274.

Original languageEnglish
Article number1364270
Pages (from-to)1-16
Number of pages16
JournalFrontiers in Neurology
Volume15
DOIs
Publication statusPublished - 9 May 2024

Keywords

  • ADHD
  • adolescents
  • efficacy
  • neuromodulation
  • rct
  • transcranial pulse stimulation

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Efficacy and safety of transcranial pulse stimulation in young adolescents with attention-deficit/hyperactivity disorder: a pilot, randomized, double-blind, sham-controlled trial'. Together they form a unique fingerprint.

Cite this